Evidence map›Paper›PMID 36037482›Full record

ArticleAmerican journal of audiology2022

Hearing Health Care Digital Therapeutics: Patient Satisfaction Evidence.

Nancy Tye-Murray, Brent Spehar, Elizabeth Mauze, Christopher Cardinal

Open access · greenAbstract read
In one paragraph

Article in American journal of audiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Adoption of Digital Therapeutics in Europe.Therapeutics and clinical risk management · 2024
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nancy Tye-MurrayDepartment of Otolaryngology, Washington University School of Medicine in St. Louis, MO.
Brent SpeharDepartment of Otolaryngology, Washington University School of Medicine in St. Louis, MO.ORCID 0000-0002-8300-1118
Elizabeth MauzeDepartment of Otolaryngology, Washington University School of Medicine in St. Louis, MO.
Christopher CardinalAmptify, St. Louis, MO.
Google (United States) · US

Funding

Auditory Brain Training to Enhance Satisfaction and Usage of New Hearing Aids by Older AdultsR43AG065075 · NIA · CUSTOMIZED LEARNING EXERCISE FOR AURAL REHABILITATION, LLC · PI CARDINAL, CHRISTOPHER ALLEN, TYE-MURRAY, NANCY ANN · 2020 to 2020
$155k
NIA NIH HHS R43 AG065075
6 · The paper itself

Abstract

purposeA digital therapeutic is a software-based intervention for a disease and/or disorder and often includes a daily, interactive curriculum and exercises; online support from a professional versed in the treatment base; and an online support community, typically active as a social chat group. Recently, the Consumer Technology Association published revised standards for digital therapeutics (DTx) that stipulate that a DTx must be evidence based and founded in scientific evidence showing effectiveness and must be supported by evidence showing improved patient satisfaction and adherence to an intervention. The purpose of this study was to investigate whether a DTx could help older adults better adjust to their hearing loss and acclimate to new hearing aids.

methodThirty older adults with mild or moderate hearing loss who had never used hearing aids participated. All hearing aids were fitted remotely. Participants used a hearing health care DTx (Amptify) for 4 weeks, either immediately following receipt of the hearing aids or 4 weeks after the fitting. A control condition was watching closed caption television. Participants completed a satisfaction questionnaire that queried about their impressions of the DTx, which had items that included both a rating scale of 1-7 and open-ended questions.

resultsNinety-six percent of the participants reported positive benefits, and one-half reported that the DTx helped them to adjust to their new hearing aids. They assigned a score of 5.8 to one of the questionnaire items that is similar to a Net Promoter Score Benefits, which included an enhanced ability to engage in conversation and increased listening confidence.

conclusionThis investigation provides scientific evidence to support the use of a hearing health care DTx, paving the way for audiologists to be able to more easily and efficiently incorporate follow-up aural rehabilitation into their routine clinical services and to be able to provide services remotely.

Indexed as

Hearing AidsHearing LossAgedHearingHumansMidazolamPatient SatisfactionMidazolam

Identifiers

PMID36037482
PMCPMC9886161
OpenAlexW4293499667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.